男性不孕市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Male Infertility Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月29日 | 出版商:

Global Market Insights Inc. | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在人們對先進治療方案的認知和獲取不斷增加的推動下，全球男性不孕症市場從 2024 年到 2032 年的複合年成長率預計將達到 4.7%。不孕症在全世界日益受到關注，影響了全球約 15% 的夫婦。據世界衛生組織 (WHO) 稱，其中近一半的病例是由男性不孕症引起的，這導致對有效治療解決方案的需求激增。

人們對男性不孕症問題的認知不斷提高，加上診斷技術和治療方法的進步，預計將推動市場擴張。此外，社會向晚育的轉變以及人們對生育治療的日益接受，進一步增加了對男性不孕症解決方案的需求。

整個男性不孕症產業根據測試、配銷通路和地區進行分類。

在藥物、手術介入和輔助生殖技術 (ART) 等各種治療選擇的推動下，治療領域將在 2024 年至 2032 年期間經歷顯著成長。其中，胞漿內單一精子注射 (ICSI) 和體外受精 (IVF) 等 ART 手術因其高成功率而越來越多的採用。荷爾蒙療法和基因編輯技術等創新療法的發展也促進了這一領域的成長。隨著越來越多的男性尋求克服不孕症挑戰的解決方案，治療領域預計將佔據相當大的市場佔有率。

到 2032 年，由於人們越來越偏好便利且謹慎的購買選擇，線上藥局預計將在男性不孕症市場中獲得顯著佔有率。電子商務平台的激增和數位健康諮詢的成長趨勢使患者可以更輕鬆地在舒適的家中獲得生育治療和藥物。網上藥局提供各種生育產品，通常價格具有競爭力，並且還提供送貨上門服務的額外好處。這種向線上購買的轉變在無法獲得專業生育診所的地區尤其重要，為患者提供了可靠且方便的不孕症治療選擇。

由於其先進的醫療基礎設施、高意識水平和支持性政府舉措，歐洲將在 2024 年至 2032 年期間推動男性不孕症市場取得可觀的進展。該地區對生殖健康的高度重視，加上對研發的大量投資，正在促進不孕症治療的創新。此外，歐洲領先的製藥公司和生育診所的存在也有助於尖端治療方法的廣泛應用。隨著越來越多的男性因不孕症尋求醫療援助，在有利的監管環境和整個地區對生育治療的接受度不斷提高的支持下，歐洲市場必將經歷大幅成長。

產業生態系統分析
產業影響力
- 成長動力
  - 診斷技術的進步
  - 輔助生殖科技的發展
  - 加強生育治療的研究與開發
  - 提高意識和教育
- 產業陷阱與挑戰
  - 治療費用高
  - 副作用和併發症
成長潛力分析
監管環境
技術景觀
- 核心技術
- 鄰近技術
2023 年定價分析
未來市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
測試
- DNA片段化技術
- 氧化壓力分析
- 顯微鏡檢查
- 精子凝集
- 電腦輔助精液分析
- 精子穿透試驗
- 其他測試
治療
- 藥物
- ART 和精索靜脈曲張手術試劑和套件

第 6 章：市場估計與預測：按配銷通路，2021 - 2032 年

主要趨勢
醫院藥房
零售藥局和藥局
網路藥局

第 7 章：市場估計與預測：按地區分類，2021 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Andrology Solutions
ASKA Pharmaceutical Co., Ltd.
AdvaCare Pharma
Bayer AG
CinnaGen Co.
CaerusBiotech
Endo International plc
HalotechDNA
Intas Pharmaceuticals Ltd.
Merck KGaA
Sanofi
SCSA Diagnostics, Inc
The Cooper Companies, Inc.
Vitrolife Group
Zydus Lifesciences Limited

簡介目錄

Product Code: 10497

The Global Male Infertility Market is poised to exhibit 4.7% CAGR from 2024 to 2032, driven by increasing awareness and access to advanced treatment options. Infertility is a growing concern worldwide, affecting an estimated 15% of couples globally. According to the World Health Organization (WHO), male infertility contributes to nearly half of these cases, leading to a surge in demand for effective treatment solutions.

The rising awareness of male infertility issues, coupled with advancements in diagnostic techniques and treatment methods, is expected to propel market expansion. Additionally, societal shifts towards later parenting and the growing acceptance of fertility treatments are further bolstering the demand for male infertility solutions.

The overall Male Infertility Industry is classified based on the test, distribution channel, and region.

The treatment segment will experience significant growth over 2024-2032, driven by the availability of various therapeutic options, including medications, surgical interventions, and assisted reproductive technologies (ART). Among these, ART procedures such as intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) are witnessing increasing adoption due to their high success rates. The development of innovative treatments, such as hormonal therapies and gene editing techniques, is also contributing to the growth of this segment. As more men seek solutions to overcome infertility challenges, the treatment segment is expected to capture a substantial share of the market.

Online pharmacies are set to gain a notable share in the Male Infertility Market by 2032, driven by the increasing preference for convenient and discreet purchasing options. The proliferation of e-commerce platforms and the growing trend of digital health consultations are making it easier for patients to access fertility treatments and medications from the comfort of their homes. Online pharmacies offer a wide range of fertility products, often at competitive prices, along with the added benefit of home delivery services. This shift towards online purchasing is particularly significant in regions with limited access to specialized fertility clinics, providing patients with a reliable and accessible option for managing their infertility treatment.

Europe will drive commendable gains in the Male Infertility Market throughout 2024-2032, owing to its advanced healthcare infrastructure, high awareness levels, and supportive government initiatives. The region's strong focus on reproductive health, coupled with significant investment in research and development, is fostering innovation in infertility treatments. Additionally, the presence of leading pharmaceutical companies and fertility clinics in Europe is contributing to the widespread availability of cutting-edge treatments. With a growing number of men seeking medical assistance for infertility issues, the European market is set to experience substantial growth, supported by favorable regulatory environments and increasing acceptance of fertility treatments across the region.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Advancements in diagnostic technologies
  - 3.2.1.2 Growth in assisted reproductive technologies
  - 3.2.1.3 Increasing research and development in fertility treatments
  - 3.2.1.4 Rising awareness and education
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of treatment
  - 3.2.2.2 Side effects and complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Test
- 5.2.1 DNA fragmentation technique
- 5.2.2 Oxidative stress analysis
- 5.2.3 Microscopic examination
- 5.2.4 Sperm agglutination
- 5.2.5 Computer assisted semen analysis
- 5.2.6 Sperm penetration assay
- 5.2.7 Other tests
5.3 Treatment
- 5.3.1 Medication
- 5.3.2 ART and varicocele surgery reagents and kits

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals pharmacies
6.3 Retail pharmacies and drug stores
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa